Luigi Mangione’s guilty plea to federal stalking-to-kill charges has raised questions about how it’ll affect his state murder case and what his lawyers might do to prevent Mangione from spending the rest of his life in prison. In a stunning turn, Mangione pleaded guilty in Manhattan federal court on Friday to a pair of stalking charges and admitted he killed UnitedHealthcare CEO Brian Thompson. Neither Mangione nor his lawyers said why he pleaded guilty and why he decided to do so now, but they gave some clues. Mangione’s lawyers have filed paperwork seeking to have the state case thrown out on double jeopardy grounds.
From
To
AP Wire
Luigi Mangione has pleaded guilty to federal stalking charges in the killing of UnitedHealthcare CEO Brian Thompson. He admitted to following Thompson to an investor conference in 2024 and shooting him on a New York City street. The 28-year-old Mangione acknowledged his actions Friday at a hastily scheduled hearing in Manhattan. At sentencing, he faces life in prison. His lawyers are now seeking to dismiss a separate New York state murder case on double jeopardy grounds. The case has become a fulcrum for debate about the healthcare industry and made Mangione a cause célèbre for some of its critics.
AP Wire
Luigi Mangione is expected to plead guilty as early as Friday in the federal case accusing him of stalking and killing UnitedHealthcare CEO Brian Thompson, a stunning development in a case that rattled business leaders while galvanizing their critics, according to a person familiar with the matter. The person was not authorized to talk publicly about the case and spoke to The Associated Press on the condition of anonymity. The person cautioned that Mangione could change his mind. Mangione is accused of stalking Thompson, 50, then shooting him outside a New York City hotel on Dec. 4, 2024, as the executive walked to UnitedHealth Group’s annual investor conference. Mangione is due in court on Friday for a hastily scheduled hearing in the federal case. Mangione’s lawyers declined to comment.